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Introduction
Acute pancreatitis is an inflammatory process
of pancreas characterized by sudden onset and is, to
date, one of the most important gastrointestinal
causes of hospitalization, with an annual worldwide
incidence ranging between 13 and 45 cases per
100.000 people(1).
In Italy its annual incidence is estimated
around 5-6 cases per 100.000 people, with an aver-
age age of onset ranging between 40 and 60 years(2).
Clinical presentation could be extremely vari-
ous, from quite asymptomatic forms, characterized
by a dyspepsia-like framework, to severe and life-
threatening ones. The mild clinical variety, also
called edematous or interstitial pancreatitis, is a self-
limiting disease with absent or minimal organ dys-
function, and usually characterized by an uneventful
recovery without complications. The severe form,
also called necrotizing pancreatitis, occurs in about
20-30% of all patients with acute pancreatitis, and is
characterized by protracted clinical course, high inci-
dence of local complications and high mortality rate.
Patients with pancreatic necrosis require to be close-
ly monitored in intensive care unit, with a strict clini-
cal and laboratory follow-up, associated with CT and
MRI examination(3).
An early assessment of severity of acute pan-
creatitis is crucial to guide therapy and is based on
the evaluation of objective parameters useful to pre-
dict clinical complications and to identify potential-
ly lethal frameworks, which occur in 2-10% of
patients suffering from acute pancreatitis. In the last
decade it has been established that the increased
frequency of death in acute pancreatitis is strictly
related to the development and extension of pancre-
atic necrosis. For this, the detection of pancreatic
necrosis (i.e. necrotizing pancreatitis) is used as a
critical prognostic indicator for the first clinical
assessment of these patients(4-6).
Prognostic assessment of acute pancreatitis
severity rank is based both on clinical and laboratory
evaluation (i.e. Ranson’s, Glasgow, and Acute
Physiology And Chronic Health Evaluation
[APACHE] II scores) and on contrast-enhanced
CT(7,8).
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ABSTRACT
Acute pancreatitis is a severe pathologic condition that requires an early identification of patients at risk of developing poten-
tially lethal complications. To date, the use of clinical scoring systems and evaluation of biochemical parameters are, by far, the most
widely used means to stratify the risk, even if they seem approximate and inadequate. The computed tomography severity index has
proved to be superior in predicting acute pancreatitis outcome. Here we report the case of an adult male, admitted to our Department
with the initial diagnosis of acute edematous pancreatitis, which was proved later to be a necrotizing pancreatitis, in which the clini-
cal and laboratory prognostic scores were inadequate and discrepant with the more accurate computed tomography severity index.
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Unfortunately, the prognostic criteria based on
clinical, laboratory and radiological evidences, are
not always effective and consistent each other. The
following case points-out the inadequacy and dis-
crepancy of the existing parameters, conceived by
scientific community and worldwide approved,
confirming the superiority of radiological criteria
on clinical-laboratory ones.
Case report
A 48-year-old male was admitted to our
Department of Internal Medicine due to the onset,
from approximately a month, of bloating and
abdominal pain localized, mainly, to the superior
quadrants, which radiated to the back, associated
with nausea and anorexia, in absence of additional
symptoms and/or signs of organ involvement. His
medical history revealed, in the last six years, sev-
eral access to Emergency Department (ED) because
of “recurrent abdominal colics”. For this, on 2010
he underwent colonoscopy (without biopsies)
which detected ‘diverticulosis of the sigmoid
colon’. About 20 days before the admission to our
Department, due to a fresh outbreak of the above
mentioned symptoms, he went to the ED where was
subjected to abdominal ultrasonography which
proved negative (the investigation was hampered
by meteorism and the pancreatic region was not
shown); blood tests were not performed. Few days
after, with the recommendation of his general prac-
titioner, he underwent esophagogastroduo-
denoscopy, which showed “esophagitis grade A,
according to Los Angeles classification, in a subject
suffering from gastroesophageal reflux, sliding
axial hiatal hernia and bulbar erosive duodenitis”.
Subsequently therapy with prokinetic drugs and
proton pump inhibitors (PPI) was started, with little
benefit. Nevertheless, due to the persistence of
symptoms, he went back to the ED of our Hospital,
where routine blood tests were performed, showing
only neutrophilic leucocytosis, while amylase,
lipase, hepatobiliary and renal function markers
where all inside the range of normality; on the con-
trary, abdominal CT scan without contrast showed a
‘volumetric expansion of head and isthmus of pan-
creas, with evidence of ectasic tubular formations
(pancreatic ducts increased in volume); hyperdensi-
ty of peripancreatic adipose tissue; centimetric
lymph nodes and fluid imbibition of anterior renal
fascia” (Figure 1). 
The patient was, then, admitted to our
Department with the diagnosis of “acute edematous
pancreatitis”. Physical examination showed pain on
deep palpation of epigastrium, mesogastrium and
left iliac fossa. Laboratory tests showed neu-
trophilic leucocytosis (WBC 16.000 x mmc, refer-
ence values 4000-11000 x mmc), while amylase,
lipase, hepatobiliary and renal function were still
normal, as well as serum calcium and blood glu-
cose. All these parameters persisted normal in sev-
eral samples carried out throughout the hospitaliza-
tion. The arterial blood gas analysis and the acid-
base balance were normal too. The application of
prognostic criteria (Tables 1-4) provided, on admis-
sion, the following results: Ranson’s Criteria: 1%
mortality rate; Glasgow score: mild acute pancreati-
tis; Apache II score: 4% approximate mortality risk;
Balthazar’s score: mortality and complications rates
3% and 8%, respectively. Based exclusively on
clinical-laboratory scores, it was formulated the
diagnosis of acute edematous pancreatitis with
favorable prognosis. Fasting and PPI intravenous
therapy were promptly started. On the second day
of hospitalization an abdominal contrast-enhanced
CT scan was performed, showing, unexpectedly,
the framework of ‘necrotic-hemorrhagic pancreati-
tis’ (Figure 2).
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Admission
Age older than 55 years Lactate dehydrogenase > 350 IU/L
Serum white blood
cell count > 16.000 mm3 Aspartate aminotransferase > 250 IU/L
Serum glucose > 200 mg/dL
Initial 48 hours
Hematocrit decrease > 10% Estimated fluid sequestration > 6 L
Blood urea nitrogen
increase > 5 mg/dL Serum Calcium < 8 mg/dL
Base deficit > 4 mEq/L PaO2 < 60 mmHg
Ranson’s prognostic scale
(96% accuracy rate)
< 3 signs = 1% mortality rate 5 or 6 signs = 40% mortality rate
3 or 4 signs = 15% mortality
rate > 6 signs = 100% mortality rate
Table 1: Ranson’s Criteria.
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PANCREAS acronym
PaO2 < 60 mmHg Age > 55 years
Neutrophils - White Cell Count > 15.000 x mm3 Serum Calcium < 2 mmol/L (8 mg/dL)
Renal Function: Urea > 16 mmol/L (44 mg/dL) Enzymes: AST/ALT > 200 IU/L or LDH > 600 IU/L
Albumin < 3.2 g/L Sugar: Glucose > 10 mmol/L (180 mg/dL)
a score ≥ 3 indicates acute severe pancreatitis
a score < 3 indicates acute mild pancreatitis
Table 2: Glasgow score.
* Sum of physiological variables, age and
chronic health problems points.
Chronic diseases includes biopsy proven cirrhosis and documented
portal hypertension; past upper gastrointestinal bleeding attributed
to portal hypertension; prior hepatic failure; prior hepatic encepha-
lopathy; NYHA class IV; chronic restrictive, obstructive, or vascular
lung disease resulting in severe exercise restriction; documented
hypoxemia or hypercapnia; secondary polycythemia; severe pulmo-
nary hypertension (>40 mmHg); ventilator dependence; chronic
hemodialysis. Chronic diseases also includes immunosuppression
from chemotherapy, radiation therapy, long-term or recent high-dose
steroids, immunodeficiency (eg, leukemia, lymphoma, AIDS).
Table 3: APACHE II score.
For this, a surgical consultation was required,
which excluded any surgery urgency, and therapy
was promptly changed with the insertion of naso-
gastric tube and the addition of intravenous
octreotide, fluoroquinolones and carbapenems. On
the second day of hospitalization, clinical-laborato-
ry scores gave the same results, whereas
Balthazar’s score raised on mortality and complica-
tions rates to 6% and 35%, respectively. On the sev-
enth day, the patient underwent to an abdominal
contrast-enhanced MRI, which confirmed the diag-
nosis of acute pancreatitis of the head and high-
lighted ‘presence of biliary sludge’ (Figure 3),
which was the reason to start therapy with
ursodeoxycholic acid. In the same day, clinical-lab-
oratory prognostic scores were still unmodified,
whereas Balthazar’s score fell down to mortality
and complications rates of 3% and 8%, respective-
ly. After twenty days of hospitalization, the patient
was discharged in good clinical condition, com-
pletely asymptomatic, and it was recommended oral
therapy with PPI + ursodeoxycholic acid.
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Grade of acute pancreatitis Points
Pancreas undamaged (grade A) 0
Altered pancreatic volume, other tissues unharmed
(grade B) 1
Altered pancreas and peripancreatic adipose tissue
(grade C) 2
Fluid peripancreatic collection
(grade D) 3
Two or more fluid collections, or gas in the tissues
around the pancreas (grade E) 4
Degree of pancreatic necrosis Points
No necrosis 0
Necrosis of 30% of pancreas 2
Necrosis of 50% of pancreas 4
Necrosis of >50% of pancreas 6
CT severity index = points for grade of acute pancreatitis +
points for degree of pancreatic necrosis.
CT severity index Mortality Complications
0-1 0% 0%
2-3 3% 8%
4-6 6% 35%
7-10 17% 92%
CT severity index = points for grade of acute pancreatitis +
points for degree of pancreatic necrosis.
Table 4: Balthazar’s score (CT severity index).
Fig. 1:abdominal CT scan without contrast on admission,
showing a volumetric expansion of head and isthmus of
pancreas associated with the presence of ectasic tubular
formations (pancreatic ducts increased in volume),
hyperdensity of peripancreatic adipose tissue, centime-
tric lymph nodes, and fluid imbibition of anterior renal
fascia.
Fig. 2: abdominal contrast-enhanced CT scan after 48
hours of hospitalization, showing necrotic-hemorrhagic
pancreatitis.
Fig. 3: abdominal contrast-enhanced MRI, on seventh
day of hospitalization, confirming the diagnosis of acute
pancreatitis (involving primary the head) and enlighte-
ning the presence of biliary sludge.
Subsequent clinical, laboratory and ultrasound fol-
low-up after 1, 4 and 12 months showed no signifi-
cant pancreatic alterations, in particular, absence of
pseudocysts.
Discussion
Several scoring systems, that combine clinical
and laboratory parameters, have been formulated to
identify patients with severe pancreatitis and stage
the disease using the presence of specific abnormal-
ities, called prognostic signs,. The first numeric sys-
tem, proposed by Ranson et al. in 1974 (hereafter,
Ranson’s Criteria), is still the most widely used. It
is based on 11 objective signs: five determined on
admission, and six after 48 hours. A high number of
risk factors correlates with increased morbidity and
mortality rates. In patients with fewer than three
signs, there is no mortality, while in those patients
with six or more signs the mortality rate rises over
50% and usually the disease is characterized by
extensive necrosis of pancreas. Unfortunately, there
is a sensibility deficit between the real severity of
disease (or the development of necrosis) and the
group of patients with three to five severe signs.
Moreover, a proper evaluation requires to complete
the 11 measurements, in a time span of 48 hours of
observation(9-11).
From this first approach, further systems have
been formulated, such as the Glasgow criteria,
focused on different parameters but, nevertheless,
with a prognostic sensibility comparable to the
Ranson’s ones. However, the Glasgow criteria have
not shown an adequate sensitivity and specificity in
the initial staging of acute pancreatitis(12-16).
Currently, the APACHE II assessment and
monitoring system is considered the more reliable,
due to its complex structure based on the analysis
of physiologic measurements, age of the patient,
and co-presence of chronic health problems.
Comparing the various systems each other, the
APACHE II is more sensitive as early prognostic
indicator, succeeding to guide the correct approach
and, moreover, it can be used during the hospital-
ization to control the patient’s response to therapy(17-
19). After 48 hours, the APACHE II score is compa-
rable (or even better) with the Ranson’s score in
distinguishing mild from severe pancreatitis, with
an elevated accuracy(7,20,21).
Balthazar’s CT severity index is an instrumen-
tal scoring system that combines CT findings to
provide an early prognostic evaluation of acute pan-
creatitis. Depending on CT frameworks ranging
from grade A to E, respectively absence of lesions
to presence of two or more fluid collections or gas
in the tissues surrounding pancreas, is assigned a
score from zero to four points. In addition, further
points are assigned according to the presence and
percentage of pancreatic necrosis, namely two
points up to 30%, four points between 30% and
50%, and six points if higher than 50%. There is a
strict statistic relationship between morbidity and
mortality rates and the scores obtained according to
the Balthazar’s criteria. Patients with a CT severity
index up to 1 showed negligible mortality and mor-
bidity rates, while patients with a score of 2-3
showed a mortality rate equal to 3% but a 8% mor-
bidity rate. In case of scores higher than 7, the mor-
tality rate is around 17% with a 92% morbidity
rate(22-24).
Unfortunately, the discrepancy between clini-
cal-laboratory prognostic scores (i.e. Ranson’s,
Glasgow, and APACHE II) and Balthazar’s CT
severity index is often significant. Comparing the
Ranson’s criteria with Balthazar’s ones, patients
with a low CT grade (A or B) may show zero to
five signs, while patients with an high CT grade (D
or E) may have one to eight severe signs after 48
hours. Most of patients with more than five
Ranson’s prognostic signs have a high CT
grade(25,26). Differently, the APACHE II numeric sys-
tem, despite its low sensitivity and specificity (56%
and 72%, respectively) in distinguishing an intersti-
tial pancreatitis from a mild necrotizing pancreati-
tis, showed a good capacity in identifying those
patients with the need for an intensive care treat-
ment and a strict monitoring(27). Surprisingly, to
date, a unique scoring system able to classify the
severity of acute pancreatitis on admission combin-
ing together clinical, laboratory and instrumental
findings has not been devised, and further clinical
studies are required to identify such a system.
Our patient, although on admission showed
clinical and laboratory prognostic factors (i.e.
Ranson’s, Glasgow and APACHE II) extremely
favorable and compatible with the initial diagnosis
of acute edematous pancreatitis, unfortunately was
affected with a necrotic-hemorrhagic form, as evi-
denced by abdominal contrast-enhanced CT scan,
notoriously with a worst and potentially unfavor-
able prognosis. This resulted in an immediate modi-
fication of the therapy previously practiced, with a
both clinical and instrumental closer monitoring,
adequate to the real severity of the disease.
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Also notable how the prognostic criteria,
excepted the Balthazar’s one, remained favorable
throughout the course of the hospitalization(4-6). In
other words, despite the severity of final diagnosis,
the clinical and laboratory prognostic indices did
not changed during the entire hospitalization, as if
our patient was suffering from a mild form of acute
pancreatitis, not requiring, therefore, a closer moni-
toring. Better was the performance of the
Balthazar’s criteria, as previously stated in the
international literature(8,28), with the confirmation of
the finding reported by the CT scan with the subse-
quent MRI(29).
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